Kocabas, U. Et Al. 2025. Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study. ESC HEART FAILURE , vol.12, no.1 , 434-446.

Kocabas, U., ERGİN, I., Yavuz, V., Altin, C., Kaplan, M., Oztekin, G. M. Y., ... Dogdus, M.(2025). Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study. ESC HEART FAILURE , vol.12, no.1, 434-446.

Kocabas, Umut Et Al. "Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study," ESC HEART FAILURE , vol.12, no.1, 434-446, 2025

Kocabas, Umut Et Al. "Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study." ESC HEART FAILURE , vol.12, no.1, pp.434-446, 2025

Kocabas, U. Et Al. (2025) . "Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study." ESC HEART FAILURE , vol.12, no.1, pp.434-446.

@article{article, author={Umut Kocabas Et Al. }, title={Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study}, journal={ESC HEART FAILURE}, year=2025, pages={434-446} }